Metabolic surgery and cancer: Protective effects of bariatric procedures
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The worldwide epidemic of obesity and the global incidence of cancer are both increasing. There is now epidemiological evidence to support a correlation between obesity, weight gain, and some cancers. Metabolic or bariatric surgery can provide sustained weight loss and reduced obesity‐related mortality. These procedures can also improve the metabolic profile to decrease cardiovascular risk and resolve diabetes in morbidly obese patients. The operations offer several physiological steps, the so‐called BRAVE effects: 1) b ile flow alteration, 2) r eduction of gastric size, 3) a natomical gut rearrangement and altered flow of nutrients, 4) v agal manipulation and 5) e nteric gut hormone modulation. Metabolic operations are also associated with a significant reduction of cancer incidence and mortality. The cancer‐protective role of metabolic surgery is strongest for female obesity‐related tumors; however, the underlying mechanisms may involve both weight‐dependent and weight‐independent effects. These include the improvement of insulin resistance with attenuation of the metabolic syndrome as well as decreased oxidative stress and inflammation in addition to the beneficial modulation of sex steroids, gut hormones, cellular energetics, immune system, and adipokines. Elucidating the precise metabolic mechanisms of cancer prevention by metabolic surgery can increase our understanding of how obesity, diabetes, and metabolic syndrome are associated with cancer. It may also offer novel treatment strategies in the management of tumor generation and growth. Cancer 2011. © 2010 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Furthermore, if both US men and women were to maintain a normal weight, 900,000 cancer deaths could be prevented.(29) The role, therefore, for intentional weight loss”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668 · cited 4×
“)(33) Data from prospective study.(6,7) Metabolic Surgery and Cancer/Ashrafian et al”
BackgroundResultInfluentialLifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613 · cited 3×
“Metabolic surgery efficiently decreases the levels of estradiol and may, therefore, contribute to a decrease in hormone-associated tumors.(15,106) Furthermore, the insulin-resistance state of obesity results in raised insulin levels that subsequently lead to reduced levels of sex-hormone-binding globulin (synthesized…”
BackgroundThe evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330 · cited 1×
“These effects occur via insulin-like growth factor 1 (IGF1) production that can activate IGF-1 and insulin receptors on normal and cancer cells via the phosphatidylinositol 3-kinase/Akt signaling pathway.(85) Furthermore, IGF-1 may stimulate production of adipocyte-derived vascular endothelial growth factor (VEGF), a…”
BackgroundDiabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020 · cited 1×
“Although intentional weight loss through lifestyle, diet, and pharmacotherapy can all achieve improvements in glucose homeostasis and diabetes, these effects are difficult to maintain in the long-term.(32) Medical weight loss can reduce diabetes-related mortality in overweight patients by one-third(45) and overall mor…”
BackgroundLong-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572 · cited 2×
“1 years.(17) When the follow-up was increased to a mean of 12.”
BackgroundWeight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 1×
“6% of patients.(9) In metabolic-surgery patients, insulin resistance has typically been measured by the Homeostasis Model Assessment (HOMA-IR) where marked improvements occur within 6 days of surgery.”
BackgroundPories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., Dolezal, J. M., et al. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00011 · Cited by 2,293 · cited 1×
“months to 1 year to develop.(89) Furthermore, in a small minority of patients, the Roux-en-Y gastric bypass procedure not only resolves diabetes but can overshoot to result in a hyperinsulinemic hypoglycemia that may result from nesidioblastosis (pancreatic beta-cell hypertrophy with islet hyperplasia) after surgery.”
BackgroundReeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
Christou, N. V., Sampalis, J. S., Liberman, M., Look, D., Auger, S., McLean, A. P. H., & MacLean, L. D. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000137343.63376.19 · Cited by 1,288
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus
Schauer, P. R., Burguera, B., Ikramuddin, S., Cottam, D., Gourash, W., Hamad, G., Eid, G. M., Mattar, S., Ramanathan, R., Barinas-Mitchel, E., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000089851.41115.1b · Cited by 1,183 · cited 1×
“8 days after surgery with no antidiabetic medication and normal plasma glucose levels.(88) Noticeable surgical weight loss, however, can take between 3 Review Article”
Metabolic/bariatric surgery worldwide 2008
Buchwald, H., & Oien, D. M. (2009) · Obesity Surgery · doi:10.1007/s11695-009-0014-5 · Cited by 826
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Sjöström, L., Gummesson, A., Sjöström, C. D., Narbro, K., Peltonen, M., Wedel, H., Bengtsson, C., Bouchard, C., Carlsson, B., Dahlgren, S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70159-7 · Cited by 770
Impact of gastric bypass operation on survival: a population-based analysis
Flum, D. R., & Dellinger, P. E. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.06.014 · Cited by 527
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000073313.16135.21 · Cited by 427 · cited 1×
“Multiple regression analysis reveals that the decrease in postoperative insulin resistance after surgery is independently associated with a decrease in interleukin-6 concentrations.(77) At 6 months after surgery, there is also an increase in the production of interferongamma, IL-12, and IL-18 that is associated with a…”
BackgroundOlbers, T., Bj??rkman, S., Lindroos, A., Maleckas, A., L??nn, L., Sj??str??m, L., & L??nroth, H. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000218085.25902.f8 · Cited by 340
Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study
Parker, E. D., & Folsom, A. R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802437 · Cited by 203 · cited 1×
“to decrease cancer rates has gained increased favor, although this has proven difficult to achieve with diet and lifestyle therapies.(30) Both randomized and prospective”
BackgroundExercise Following Bariatric Surgery: Systematic Review
Livhits, M., Mercado, C., Yermilov, I., Parikh, J. A., Dutson, E., Mehran, A., Ko, C. Y., & Gibbons, M. M. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0096-0 · Cited by 197 · cited 1×
“Furthermore, metabolic surgery patients can find increased physical activity more feasible after surgery where the degree of postoperative weight loss is associated with increased levels of exercise.(31,66) These operations may offer some anticancerous effects through increased physical activity as this can decrease m…”
BackgroundCRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects
Holdstock, C., Lind, L., Engstrom, B. E., Ohrvall, M., Sundbom, M., Larsson, A., & Karlsson, F. A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803000 · Cited by 73
Bariatric surgery, weight reduction, and cancer prevention
Renehan, A. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70170-6 · Cited by 58
Ghrelin in neuroendocrine organs and tumours
Leontiou, C. A., Franchi, G., & Korbonits, M. (2007) · Pituitary · doi:10.1007/s11102-007-0023-0 · Cited by 40
Cited by
Mechanick, J. I., Youdim, A., Jones, D. B., Garvey, W. T., Hurley, D. L., McMahon, M. M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., et al. (2013) · Obesity · doi:10.1002/oby.20461 · Cited by 1,650
Mechanick, J. I., Youdim, A., Jones, D. B., Timothy Garvey, W., Hurley, D. L., Molly McMahon, M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., et al. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.12.010 · Cited by 703
Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk
Li, J. V., Ashrafian, H., Bueter, M., Kinross, J., Sands, C., le Roux, C. W., Bloom, S. R., Darzi, A., Athanasiou, T., Marchesi, J. R., et al. (2011) · Gut · doi:10.1136/gut.2010.234708 · Cited by 446
Self-citationMechanick, J. I., Youdim, A., Jones, D. B., Garvey, W. T., Hurley, D. L., McMahon, M. M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., et al. (2013) · Endocrine Practice · doi:10.4158/ep12437.gl · Cited by 395
Yeung, K. T. D., Penney, N., Ashrafian, L., Darzi, A., & Ashrafian, H. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003275 · Cited by 350
Self-citation
Metadata
- Authors
- Ashrafian, H., Ahmed, K., Rowland, S. P., Patel, V. M., Gooderham, N. J., Holmes, E., Darzi, A., & Athanasiou, T.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-11-29
- Volume
- 117
- Issue
- 9
- Pages
- 1788-1799
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1542270391
- Cited by
- 149
- References
- 29
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.